2021-12-04Shen Wenwen of AVIC Securities Co., Ltd. conducted a study on Kangchen Pharmaceutical and released a research report "Incident Review: Clinical Application of Teripatoide Accepted, Orthopedic Treatment...
12-05
Zhitong Financial APP News, Kangchen Pharmaceutical (603590.SH) announced that the company received GLGLEEInvestmen on November 12, 2021...
11-15
![On November 12, Kangchen Pharmaceutical traded 503,000 shares at 31.50 yuan per share, a premium of 2.24%[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)
On November 12, Kangchen Pharmaceutical (603590) recently issued an announcement that the company's shareholder GLGLEEInvestmentHongKongLim...
11-15
On November 12, 2021, Kangchen Pharmaceutical (603590.SH) announced that the company received the "About Beijing Kangchen Pharmaceutical Shares" from GL on November 12, 2021.
11-15
In order to protect bone health and help healthy China 2030 strategy, the city tour of "Expert Consensus on The Prevention and Treatment of Acute Bone Loss in Orthopedics" was first stationed in kangchen pharmaceutical (603590) vigorously...
11-08
On November 8, Gelonghui Announced that Kangchen Pharmaceutical (603590.SH) announced that the company recently received the "On the Reduction of Shares of Beijing Kangchen Pharmaceutical Co., Ltd." sent by Beijing Gongtou.
11-08
Kangchen Pharmaceutical (603590.SH) announced that as of November 6, 2021, the Company's shareholder, Beijing Industrial Development Investment Management Co., Ltd. ("...
11-08
Recently, Kangchen Pharmaceutical (603590) launched a fixed capital increase plan to enter the orthopedic drug market through mergers and acquisitions. On the evening of April 21, Kangchen Pharmaceutical issued an announcement that it intends to raise...
11-07
On March 22, Kangchen Pharmaceutical (603590) recently released its 2020 annual report, and the company achieved operating income of 808,643,947.92 during the reporting period.
11-07
Zhitong Financial APP News, Kangchen Pharmaceutical (603590.SH) announced that the company's 1.31% shareholder GLGLEEInvestmentHongKo...
11-07
Intern reporter | Zhou Tianyi on the evening of September 11, Kangchen Pharmaceutical (603590. SH) issued an announcement that the company's shareholder GLGLEEInvestmentHong...
11-07
Kangchen Pharmaceutical, which has been listed for less than two years, can't wait to launch a fixed increase plan and circle money fiercely. Reporter Du Peng/Wen Recently, Kangchen Pharmaceutical (603590. SH) announced a fixed increase in capital...
11-07
Kangchen Pharmaceutical: Shareholders intend to reduce their holdings by no more than 2.103 million shares of China Securities Network News (reporter Yang Peng) Kangchen Pharmaceutical (603590) announced on the evening of November 2 that the company's shareholder GLGL...
11-03
Kangchen Pharmaceutical announced that as of October 31, 2021, the company has repurchased 2,273,523 shares through centralized auction transactions, accounting for the proportion of the company's total share capital...
11-01
Zhitong Financial APP News, Kangchen Pharmaceutical (603590.SH) released the third quarter report of 2021, the company's operating income from the beginning of the year to the end of the reporting period was 597 million yuan, a year-on-year...
10-27
2021-10-26Li Zhixin of Capital Securities Co., Ltd. conducted a study on Kangchen Pharmaceutical and released a research report "Brief Evaluation Report of the Company: Kangchen Pharmaceutical: The Third Quarterly Report Meets Expectations...
10-27
Zhitong Financial APP News, Kangchen Pharmaceutical (603590.SH) issued an announcement that the company held the 22nd meeting of the third board of directors on October 25, 2021.
10-27
